mTOR expression also rose, suggesting enhanced protein synthesis
PubMed pubmed.ncbi.nlm.nih.gov [87] Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis ScienceDirect [88] GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review ScienceDirect
[DOI] [PubMed] [Google Scholar] 25.Booth D.M., Mukherjee R., Sutton R., Criddle D.N
MOTS-c has no relationship to this axis at all
Oh, and a quick note: the standard version has dairy, but if youre sensitive (like my cousin, whos lactose-intolerant), they swap in almond, oat, or coconut milk with zero hassle
So, just to remind listeners that semaglutide targets a pathway called GLP-1